Pilar Llamas Selected Research

Pilar Llamas Research Topics

Disease

6	Thrombosis (Thrombus) 01/2022 - 08/2002
4	Neoplasms (Cancer) 12/2020 - 01/2018
3	Venous Thromboembolism 05/2022 - 05/2008
3	COVID-19 01/2022 - 10/2020
3	Hemorrhage 01/2022 - 01/2016
3	Venous Thrombosis (Deep-Vein Thrombosis) 06/2021 - 08/2002
2	Pulmonary Embolism 05/2022 - 06/2021
2	Inflammation (Inflammations) 01/2022 - 04/2008
2	Critical Illness (Critically Ill) 01/2022 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020 - 07/2003
2	Anterior Uveitis 01/2017 - 01/2016
1	Pneumonia (Pneumonitis) 01/2022
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Lymphoma (Lymphomas) 01/2018
1	Rheumatoid Arthritis 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2016
1	Atrial Fibrillation 01/2014
1	Myocardial Infarction 05/2008
1	Thrombophilia 05/2008
1	Disease Susceptibility (Diathesis) 04/2008
1	Brain Injuries (Brain Injury) 04/2008
1	Ischemic Stroke 04/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2008
1	Stroke (Strokes) 04/2008
1	Legg-Calve-Perthes Disease (Perthes Disease) 07/2005
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2003

Drug/Important Bio-Agent (IBA)

4	AnticoagulantsIBA 01/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2008
3	Prothrombin (Factor II)IBA 05/2008 - 08/2002
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
2	factor V LeidenIBA 05/2008 - 07/2005
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 05/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	bemiparinIBA 01/2022
1	Factor Xa InhibitorsIBA 01/2022
1	PRT064445IBA 01/2022
1	idarucizumabIBA 01/2022
1	Dabigatran FDA Link 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	VaccinesIBA 12/2021
1	BNT162 VaccineIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	AcenocoumarolIBA 06/2021
1	Ferritins (Ferritin)IBA 01/2021
1	fluorocitrateIBA 12/2020
1	Aconitate Hydratase (Aconitase)IBA 12/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Patched-1 ReceptorIBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Abatacept (Orencia)FDA Link 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Protein Sorting Signals (Signal Peptide)IBA 01/2016
1	DipeptidesIBA 01/2016
1	PolymersIBA 01/2016
1	SteroidsIBA 01/2016
1	AntithrombinsIBA 01/2016
1	Vitamin K FDA Link 01/2014
1	Blood Group Antigens (Blood Groups)IBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 04/2008
1	Interleukin-6 (Interleukin 6)IBA 04/2008
1	CytokinesIBA 04/2008
1	Complement System Proteins (Complement)IBA 04/2008
1	Interferon-alpha (Interferon Alfa)IBA 07/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2003
1	Prednisone (Sone)FDA LinkGeneric 07/2003
1	Vincristine (Oncovin)FDA LinkGeneric 07/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2008
2	Length of Stay 06/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 10/2020 - 07/2003
1	Anticoagulation Reversal 01/2022
1	Resuscitation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Slit Lamp 01/2017